MedTrace Logo

Global Patient Registry of Inherited Retinal Diseases

NCT05957276 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 889

Last updated 2026-05-08

No results posted yet for this study

Summary

The purpose of this study is to better understand the natural history of Inherited Retinal Disease (IRD) and help inform patient management.

Conditions

Interventions

OTHER

Standard of Care

Participants will not receive any intervention in this study. Participants will receive standard of care therapy.

Sponsors & Collaborators

  • Janssen Research & Development, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Research & Development, LLC Clinical Trial · Janssen Research & Development, LLC

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2026-07-03
Completion
2026-07-03

Countries

  • United States
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • China
  • Denmark
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Japan
  • South Korea
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05957276 on ClinicalTrials.gov